173 related articles for article (PubMed ID: 20149060)
1. Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
Furuse C; Miguita L; Rosa AC; Soares AB; Martinez EF; Altemani A; de Araújo VC
J Oral Pathol Med; 2010 Aug; 39(7):540-7. PubMed ID: 20149060
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC
Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
[TBL] [Abstract][Full Text] [Related]
4. FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study.
Miguita L; Martinez EF; de Araújo NS; de Araújo VC
J Appl Oral Sci; 2010; 18(1):83-91. PubMed ID: 20379686
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
6. Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
Head Neck Pathol; 2007 Dec; 1(2):112-7. PubMed ID: 20614261
[TBL] [Abstract][Full Text] [Related]
7. Maspin expression in carcinoma ex pleomorphic adenoma.
Martins MT; Altemani A; Freitas L; Araújo VC
J Clin Pathol; 2005 Dec; 58(12):1311-4. PubMed ID: 16311353
[TBL] [Abstract][Full Text] [Related]
8. S100P expression in ductal type of carcinoma ex pleomorphic adenoma.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706
[TBL] [Abstract][Full Text] [Related]
9. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
[TBL] [Abstract][Full Text] [Related]
10. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS
Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205
[TBL] [Abstract][Full Text] [Related]
11. The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Tincani AJ; Martins AS; Altemani A; de Araújo VC
J Clin Pathol; 2012 Mar; 65(3):272-7. PubMed ID: 22174424
[TBL] [Abstract][Full Text] [Related]
12. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
Lewis JE; Olsen KD; Sebo TJ
Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
[TBL] [Abstract][Full Text] [Related]
16. Biomarker analysis in carcinoma ex pleomorphic adenoma at an early phase of carcinomatous transformation.
Freitas LL; Araújo VC; Martins MT; Chone C; Crespo A; Altemani A
Int J Surg Pathol; 2005 Oct; 13(4):337-42. PubMed ID: 16273189
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma ex pleomorphic adenoma of the parotid gland.
Kashiwagi N; Murakami T; Chikugo T; Tomita Y; Kawano K; Nakanishi K; Mori K; Tomiyama N
Acta Radiol; 2012 Apr; 53(3):303-6. PubMed ID: 22287150
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
20. Tenascin and fibronectin expression in carcinoma ex pleomorphic adenoma.
Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):48-53. PubMed ID: 18091320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
